Simon Schwartz Navarro Senior scientist and advisor with specific interest in Nanomedicine and Advanced Therapies applied to unmet clinical needs. I am also acting as strategy coordinator to facilitate programs and initiatives that foster innovation in new treatments and diagnostic tools. Institutions of which they are part Main researcher Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT) Vall Hebron Institut de Recerca Cap de Secció Bioquímica Cross-departmental services LinkedIn Twitter Orcid Simon Schwartz Navarro LinkedIn Twitter Orcid Institutions of which they are part Main researcher Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT) Vall Hebron Institut de Recerca Cap de Secció Bioquímica Cross-departmental services Senior scientist and advisor with specific interest in Nanomedicine and Advanced Therapies applied to unmet clinical needs. I am also acting as strategy coordinator to facilitate programs and initiatives that foster innovation in new treatments and diagnostic tools.
Currently acting as Strategy director of biobanking and bioresources at Vall d'hebron Campus. President of the European Society of Nanomedicine and Executive Board member of the International Society of Nanomedicine. Former director general of the Blood and Tissue Banc of Catalonia. Former director of CIBBIM-Nanomedicine. Former scientific associate director of CIBER-BBN and coordinator of technology transfer. Former director assistance of translational research at VHIR. H-index of 40, with more that 115 high impact publications and 17 transferred patents. Co-founder of 3 biotech companies (i.e, Bsure Medical ltd). Science Advisor of the European Nanomedicine Characterization Laboratory (EU-NCL). Member of the editorial Board of Precision Nanomedicine, J. Nanotechnology and of J. of Nanotheranostics. Former editorial Board member of Eur. J. Nanomedicine and Nanomedicine-NBM.
Projects Aplicabilidad clinica del analisis de la inestabilidad de microsatelites en el cancer colorectal. diagnostico molecular del cancer colorectal hereditario no polipoide (hnpcc) y protocolos alternativos de diagnostico. IP: Simon Schwartz Navarro Collaborators: José Manuel Pena Ezquerra, Jordi Giralt López de Sagred, Manuel Armengol Carrasco, Eloy Espín Basany Funding agency: Instituto de Salud Carlos III Funding: 95861.43 Reference: 01/1350 Duration: 17/07/2001 - 31/12/2003 Pagination First page « Previous page ‹ … Page 7 Page 8 Page 9 Page 10 Current page 11
